Electrochemical skin conductance and Quantitative Sensory Testing on Fibromyalgia.
An impairment of the peripheral nervous system has been suggested in fibromyalgia (FM). Non-invasive distal electrochemical skin conductance (ESC) has been little studied so far when combined with quantitative sensory testing (QST) in FM patients. This study (clinicaltrials.gov NCT03347669) included 50 FM female patients and 50 matched volunteers (HV). ESC (microsiemens, µS) measured with Sudoscan®, psychological, quality of life, sleep and social characteristics were assessed in both groups. In a subgroup of 24 FM and 24 HV, QST of cold and warm detection and pain thresholds and descending inhibitory pain controls (DNIC) were explored. Statistical analysis was performed for a two-sided type I error at 5%. Between FM patients and controls, ESC measures differed (71.4 ± 11.2 versus 74.4 ± 10.3 µS, p = 0.003) especially on the dominant hand (p = 0.03), where more patients had ESC < 66 µS than in HV (p = 0.046). No difference was observed on feet. In FM, all collected characteristics were impaired (p<0.001), DNIC was less functional, detection thresholds occurring later and pain thresholds earlier. No correlation was observed between ESC and DNIC nor with any parameter. This study shows that the sudomotor function is significantly impaired in FM patients especially on the dominant hand. This occurs in parallel with adjustments of detection and pain thresholds in the context of deficient spinal pain modulation. ESC measures combined with QST are relevant in the context of FM patients and need to be explored further in this nociception-autonomic system intertwining.